Why we love Lilly

We have written about Eli Lilly a lot lately because it has recently received the highly sort after Vestact stamp of approval. Most of the focus is on their weight-loss drug Zepbound which has only just hit the market. . Keep in mind that before all this excitement Eli Lilly was already a well-established player with a diversified portfolio of pharma brands.

Take a look at the image below from App Economy Insights which shows their various products and their contribution to sales.

Trulicity and Mounjaro are both type 2 diabetes drugs that also have weight-loss side effects. In fact Zepbound was born out of Mounjaro. It has the same active pharmaceutical ingredient but is used to address different conditions, in different dosages. Verzenio is a breast cancer treatment, Jardiance is for managing blood sugar levels in diabetics, Taltz treats various autoimmune diseases, Humalog also treats diabetes, Cyramza fights colorectal cancer and Olumiant tackles Rheumatoid arthritis.

It is nice to know that this business has a stable underpin and is not just a one-trick pony.